Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Read our news
-
Articles April 4, 2023SFB & TERMIS Americas
As part of the development of HTL innovation and R&D projects, HTL was the proud gold sponsor of the SFB and silver sponsor of the Termis Americas this year.
Two very interesting congresses promoting Tissue Engineering, Regenerative Medicine and Biomaterials.
-
Articles March 14, 2023HTL team in Korea and China
March 14, 2023
-
Articles January 26, 2023HTL participation at IMCAS
January 26, 2023
-
Press releases June 8, 2022François Fournier as new CEO
HTL accelerates its development strategy with the appointment of François Fournier as Chief Executive Officer (CEO).
-
Press releases March 10, 2022GelMEDIX investment
HTL announces its incubator’s equity investment in GelMEDIX, an early-stage biotech aiming at revolutionizing ocular and regenerative therapies.
-
Press releases February 28, 2022Montagu as new investor
HTL announces Montagu as new investor alongside its historical shareholders, Naxicap and Téthys Invest.
-
Press releases September 30, 2021HTL launches a new bioproduction unit HTL4
HTL launches a new, cutting-edge bioproduction unit for pharmaceutical-grade biopolymers.
-
Press releases September 14, 2021BMG Pharma and HTL sign a development agreement
BMG Pharma and HTL sign a development agreement to manufacture BMG’s new biopolymer based on the Hyaluromimethic® Technology
-
Press releases September 8, 2021Eirion Therapeutics Announces Strategic Agreement
Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion’s Exclusive Botulinum API Manufacturer.
-
Press releases May 10, 2021Terasaki Institute Memorandum of Uderstanding
HTL Biotechnology and Terasaki Institute for Biomedical Innovation announce Memorandum of Understanding for research in translational biomaterials.
-
Press releases April 13, 2021HTL Biotechnology & Echelon Biosciences strategic partnership
HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership to advance biopolymer platform and hyaluronic acid research tools